As made ever more evident by the Covid-19 pandemic, health data-sharing can significantly contribute to research, new services and improve healthcare outcomes. The role of data in health is also on the policy agenda of the European Commission, with a ‘data space’ for health expected to be created at EU level over the next few years. Barriers across policy areas, however, hinder data-sharing and the development of a digital health ecosystem in the EU.
This study provides a comprehensive overview of the problems that affect the development of digital health solutions in the EU. It maps the regulatory barriers and market deficiencies that have so far hampered health data sharing and the creation of potential EU-wide business-to-business health data marketplaces, with a focus on type 2 diabetes data and unified diabetes-related datasets. The study relies on an extensive review of the state of the art as well as detailed input from stakeholders in the health data ecosystem.
Part of the project “Big Data and B2B platforms: the next big opportunity for Europe”, this study was funded by the Executive Agency for Small and Medium-sized Enterprises (EASME) and the European Commission. Similarly, a report on regulatory barriers and market deficiencies in the field of cooperative, connected and automated mobility was also prepared.
